Öztürker Zeynep Kayaarasi, Öztürker Can, Bayraktar Sukru, Altan Cigdem, Yilmaz Omer Faruk
1 Istanbul Education and Research Hospital , Istanbul, Turkey .
J Ocul Pharmacol Ther. 2014 Sep;30(7):554-8. doi: 10.1089/jop.2014.0008. Epub 2014 Jun 11.
To investigate the influence of preoperative antiglaucoma medications on trabeculectomy outcome.
Two hundred fifteen eyes, which underwent primary trabeculectomy, were retrospectively analyzed. The average follow-up was 39.8±30.3 months. The only cases of primary open-angle glaucoma, with or without pseudoexfoliation (PXF), were included. "Complete success" was defined as intraocular pressure (IOP) <18 mmHg without glaucoma medications, whereas relative success was defined as the same IOP target with medications. The influence of the preoperatively used glaucoma medications on surgical success was analyzed by univariate Pearson correlation and multivariate (ordinal) regression analysis.
There were 118 male (54.9%) and 97 female (45.1%) patients with a mean age of 66.9±9.3 years. PXF glaucoma (PXFG) was present in 93 eyes (43.3%). In 33 patients (15.3%), diabetes mellitus (DM) was present. Complete success was achieved in 116 eyes (54%), relative success in 81 eyes (37.6%), and failure in 18 eyes (8.4%). Neither the total number nor the duration of glaucoma medications used before trabeculectomy was found to have any statistically significant influence on surgical success. In statistical analysis, a combination of topical beta-blocker and carbonic anhydrase inhibitor (BB+CAI) used before surgery was found to be associated with statistically better outcome, whereas the preoperative use of topical beta-blockers alone could have a negative influence on success. PXF was shown to be independently associated with trabeculectomy outcome on multivariate regression analysis.
The glaucoma medications used preoperatively were not found to have any statistically significant negative influence on the trabeculectomy outcome and use of the combined BB+CAI preparation could have a positive influence, whereas the use of topical beta-blockers alone could have a negative influence on success, although not statistically significant. The presence of PXF was independently associated with a better surgical outcome.
探讨术前抗青光眼药物对小梁切除术预后的影响。
回顾性分析215例行原发性小梁切除术的患眼。平均随访时间为39.8±30.3个月。纳入仅患有原发性开角型青光眼(无论有无假性剥脱综合征[PXF])的病例。“完全成功”定义为不用抗青光眼药物时眼压(IOP)<18 mmHg,而相对成功定义为使用药物时达到相同的眼压目标。通过单因素Pearson相关性分析和多因素(有序)回归分析,分析术前使用的抗青光眼药物对手术成功的影响。
共有118例男性(54.9%)和97例女性(45.1%)患者,平均年龄为66.9±9.3岁。93只眼(43.3%)患有PXF青光眼(PXFG)。33例患者(15.3%)患有糖尿病(DM)。116只眼(54%)实现了完全成功,81只眼(37.6%)实现了相对成功,18只眼(8.4%)失败。未发现小梁切除术之前使用的抗青光眼药物的总数或使用时间对手术成功有任何统计学上的显著影响。在统计分析中,发现术前联合使用局部β受体阻滞剂和碳酸酐酶抑制剂(BB+CAI)与统计学上更好的预后相关,而术前单独使用局部β受体阻滞剂可能对手术成功有负面影响。多因素回归分析显示,PXF与小梁切除术的预后独立相关。
未发现术前使用的抗青光眼药物对小梁切除术的预后有任何统计学上的显著负面影响,联合使用BB+CAI制剂可能有积极影响,而单独使用局部β受体阻滞剂可能对手术成功有负面影响,尽管无统计学意义。PXF的存在与更好的手术预后独立相关。